COLIN DIAS: Open Payments
NPI 1811029168 · AGOURA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 15 payments from 3 companies in 2025. Trend: 2023 $150 · 2024 $150 · 2025 $364
Food & beverage: $252Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $250 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Luye Pharma (USA) Ltd. | 2 | $28 |
Products named: UZEDY, COBENFY, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
